Hutch News
Results per Page:
Latest Fred Hutch research on COVID-19
How Hutch scientists have been tackling coronavirus in lab and clinic
What Hutch coronavirus experts are saying about omicron
Some answers, but many questions, about highly mutated new variant of COVID-19 virus
Will SARS-CoV-2 become endemic?
From the Halloran lab, Biostatistics, Bioinformatics, and Epidemiology Program, Vaccine and Infectious Disease Division
There’s no crystal ball for modeling the pandemic
Mathematical modelers explain challenges, limitations of their work to predict COVID-19 outcomes
Media timeline: coronavirus coverage
A timeline of key articles about our efforts around COVID-19
COVID-19: What our scientists are saying
Fred Hutch researchers provide their insights and ideas on the pandemic
Dr. M. Elizabeth ‘Betz’ Halloran elected to National Academy of Medicine
Statistician honored for helping the world anticipate, manage and prevent infectious disease outbreaks
Dr. M. Elizabeth ‘Betz’ Halloran receives Nathan Mantel Lifetime Achievement Award
Biostatistician honored for her landmark contributions to statistical methods for infectious disease epidemiology
First licensed dengue vaccine withstands rainy season
From the Vaccine and Infectious Disease Division
New partnership seeks to increase access to lifesaving stem-cell transplants
Celebrating faculty and staff achievements
To protect, or to enhance? That is the question for Dengue virus antibodies
From Dr. Halloran, Vaccine and Infectious Disease Division
Reconstructing Zika’s travels in the Americas
From the Vaccine and Infectious Disease Division and the Center for Inference and Dynamics of Infectious Diseases
Genomic sequencing offers new clues to Zika's spread from Brazil to the Caribbean to Miami
Genomic sequencing offers new clues to the virus’ spread from Brazil to the Caribbean to Miami
Good News: Dr. Betz Halloran wins award in Rome; Hutch nominated for SLU nonprofit of the year; Obliteride amassed $2.4M in donations
Celebrating faculty and staff achievements
Tracking the rise and fall of Ebola in Sierra Leone
Study pins numbers on outbreak’s devastation, interventions that worked
Zika virus: 6 key things we don’t yet know
From lack of data to inconclusive blood tests to the unique challenges of pregnancy, experts weigh in on the knowledge gaps in this emerging infection
Ebola lessons applied to vaccine clinical trials
3 proposals for ‘thinking outside the box’ in public health emergencies
A warning heeded yields good news on Ebola
Disease modeling shows that treatment centers, safe burials are containing outbreak in Liberia
MIDAS touch: New Fred Hutch center to play key role in global disease response
Top award grants $12.5 million over five years to model and track pathogens from polio to Ebola